Showing results (1691-1700 of 9,979) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|March 26, 2002
Rituximab toxicity in patients with peripheral blood malignant B-cell lymphocytosisS Kanelli, S M Ansell, T M Habermann, et al.Leukemia & Lymphoma|March 26, 2002
CD40 ligand immunotherapy in cancer: an efficient approachN Kuwashima, S Kageyama, Y Eto, et al.Leukemia & Lymphoma|March 26, 2002
Cure of pulmonary Rhizomucor pusillus infection in a patient with hairy-cell leukemia: role of liposomal amphotericin B and GM-CSFB Ma, J F Seymour, H Januszewicz, et al.Leukemia & Lymphoma|March 26, 2002
Hemophagocytic syndrome associated with inappropiate secretion of antidiuretic hormone in lymphoma and acute myeloblastic leukemia: report of two casesF Demirkan, F Vural, G H Ozsan, et al.Leukemia & Lymphoma|March 26, 2002
Jejunal perforation in a patient with adult T-cell leukemiaH Isomoto, K Ohnita, M Haraguchi, et al.Leukemia & Lymphoma|April 24, 2019
Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphomaBastian von Tresckow, Michelle Fanale, Kirit M Ardeshna, et al.Leukemia & Lymphoma|April 25, 2019
The prognostic value of toll-like receptor5 and programmed cell death-ligand1 in patients with peripheral T-cell non-Hodgkin lymphomaMengqi Sun, Wenjia Su, Jingrong Qian, et al.Leukemia & Lymphoma|April 25, 2019
Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practicePaul J Hampel, Wei Ding, Timothy G Call, et al.Leukemia & Lymphoma|September 21, 2018
Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosisKamal Menghrajani, Philip S Boonstra, Jessica A Mercer, et al.Pageof 998